NATCO Pharma shares sinks 28% in 2 days on Q3 earnings miss, brokerage downgrade

February 14, 2025

NATCO Pharma shares tumbled 10% on Friday, extending a two-day slump to 28% after weak Q3 results and a target price cut by Nuvama. Profit fell 37.75% YoY, impacted by lower formulations exports and Agrochem weakness. Despite a strong U.S. pipeline and cash reserves, analysts remain cautious on near-term growth.

More To Explore

Voluntary pension scheme for all on cards: Won’t be tied to employment, will be open for all

India is exploring a Universal Pension Scheme that is voluntary and contributory, aimed at offering social security to all individuals. The scheme will incorporate existing

February 25, 2025

Listed startups get a delivery of reality: It’s hot on the Street

The tide is expected to turn for some of the companies including Swiggy and Mobkwik over the next few quarters. ETIG offers a snapshot of

February 25, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003